[1] |
WEI Feng, HE Yang, FAN Zhiqiang, LIU Shikun, OUYANG Linqi.
Inhibitory effect of flufenidone on TGF-β1/Smads pathway in hepatocytes of rats with diethylnitrosamine (DEN)-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 739-746.
|
[2] |
CHEN Sen, FAN Chang, ZHANG Jiafu, MA Yanzhen, JIANG Hui.
The mechanism of Shugan Jianpi Formula regulating TLR4/MyD88/NLRP3 signaling axis to inhibit pyroptosis in mice with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1081-1089.
|
[3] |
ZHENG Qiongna, WU Qiaoqiao, MA Zhele, ZHANG Xianfei, GAN Fangmin, KONG Qingming.
Interventional effect of low molecular weight heparin on mice with experimental hepatic fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 511-516.
|
[4] |
HUA Xiao-ping, ZHANG Li, HUANG Li, TAN Zheng-huai, CHEN Zhuang.
Morphological differences of liver between two liver fibrosis models induced by dimethylnitrosamine and thioacetamide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 747-751.
|
[5] |
PAN Chun-xiao, TANG Jie, WANG Xiao-yu, WANG Wen, LIU Jia-li, WU Fan-rong, CHEN Fei-hu.
Effects of acid-sensing ion channel 1a on acid-induced activation of Hepatic stellate cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(5): 528-533.
|
[6] |
YE Lei, LI Jian-shuang, CHEN Zhi-yun, YAN Mao-xiang, HE Pei-hui.
The role of ginkgo biloba extract on the hepatic GRP78 and CHOP expression in rats with liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 377-380.
|
[7] |
SONG Li-ying, PENG Xiang-dong, WANG Chun-jiang, GUO Ren, LIU Shi-kun.
Recent progress in the role of miRNA in hepatic stellate cells activation and the chronic hepatic diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1422-1428.
|
[8] |
ZHUANG Rang-xiao, WANG Fu-gen, SHAO Yi-dan, FANG Hong-ying, SUN Jing-jing, XI Jian-jun, PAN Jin-ming, LIANG Wei-feng, LIU Shou-rong.
Experimental study of acetylcysteine magnesium-glycyrrhizin fine antipode dimers on rat liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1337-1341.
|
[9] |
FU Ling-zhu, ZHENG Ting, ZHANG Yong-sheng.
Advances in understanding the role of TGF-β/Smad signalling pathways in the pathogenesis of liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1189-1195.
|
[10] |
ZHU Yan-hong, CHEN Zhen, QIAN Zhi-yu, HU Hui, CHENG Wen-yuan.
Effects of crocetin on proliferation and collagen synthesis of hepatic stellate cell
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 841-846.
|
[11] |
CHENG Zhi-yun, PENG Jun-chun, LV Ying-hui.
Role of epithelial-mesenchymal transition in the liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 928-936.
|
[12] |
JIANG Hui, GAO Jia-rong, CHEN Jin-feng, LIU Yong.
Hepatoprotective effect of Panax notoginseng saponins in hepatic fibrosis rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(10): 1116-1120.
|
[13] |
WANG Zhi-yong, WU Jun-hua, WANG Yu-rong, YU De-cai, DING Yi-tao.
Effects of tectorigenin on the secretion of extracellular matrix in Hepatic stellate cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(2): 175-180.
|
[14] |
YU Juan, HU Gui-fang, WENG Sheng-mei.
Protective effects of 13-MTD on injury of SH-SY5Y neuroblastoma cells induced by hydrogen peroxide
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(6): 622-626.
|
[15] |
SONG Biao, CHEN Zhi-wu, FAN Yi-fei.
Effects of H2O2 and 11,12-EET in EDHF mediated relaxation in the rat basilar arteries
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 121-125.
|